Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 44.64m |
Free float | 43.81m |
P/E (TTM) | 17.60 |
Market cap | 17.88bn USD |
EPS (TTM) | 22.75 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
More ▼